BES 2019

Androgen Insensitivity Syndrome can be due to a dimerization defect in the androgen receptor

001

Sexual Dimorphism in Bone Size is Mediated by Neuronal ER alpha (ERα) Signaling in Females during Late Puberty

002

Impact of changes in muscle secretome in the improvement of glucose homeostasis induced by bariatric surgery

003

Misclassification of fractures by self-report: an analysis from the FRISBEE cohort

004

Serum levels of Wnt-signalling parameters poorly reflect bone mass and metabolism in healthy boys and men

005

Endocrine consequences of immune checkpoint inhibitors

006

Low dose continuous IV etomidate for severe Cushing’s syndrome in the non-critical care setting: a clinical study

007

Study of neuroendocrine deficits in a series of 74 patients following traumatic brain injury

008

Risk of Malignancy of the Thyroid Nodule Evaluated by Scintigraphy

009

Effect of nationwide reimbursement of sensor-augmented pump therapy in a paediatric type 1 diabetes population on HBA1C, hypoglycaemia and quality of life: the rescue-paediatrics study

010

Effect of exogenous testosterone administration on serum oestradiol levels in assigned female at birth transgender people: result from a large transgender cohort

011

Evolution of Circulating Thyroid Hormone Levels in Preterm Infants during the First Week of Life: Perinatal Influences and Impact on Neurodevelopment

012

The interpretative value of CGM-derived parameters in type 1 diabetes depends on the level of glycaemic control

013

No deleterious effect of pretreatment with everolimus and/or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT

014

Impaired Hypoglycemia Awareness in children and adolescents with type 1 diabetes

015

Is it worthwhile to distinguish between grade 1 and grade 2 subclinical hyperthyroidism for alteration of metabolic parameters?

016

Value of [11C]-methionine PET/CT in preoperative localization of adenomas in primary hyperparathyroidism

017

Osteoporosis Treatment Gap in the FRISBEE cohort

018

Androgen metabolism during weight loss in men with obesity

019

Uncontrolled gender-affirming hormone use in transgender sex workers in Antwerp

020

Characterisation of testicular function and spermatogenesis in transgender women

021

Hyperparathyroidism in a patient with sickle cell disease

022

Hypercalcemia as a rare complication of anti-tumor necrosis factor alpha: a case-report and literature study

023

A case of meningioma after cyproterone acetate use

024

A rare cause of central diabetes insipidus

025

An adrenal tumor with gynecomastia

026

Catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage: a case report

027

A cherry-tomato like thyroid

028

ACTH-dependent hypercortisolism: always follow your nose

029

A sarcoidosis-lymphoma syndrome revealed by hypopituitarism

030

A novel pathogenic mutation in neurofibromatosis type 1

031

Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor

032

A rare double cause of primary hyperparathyroidism

033

An unusual case of pubertas tarda: IGSF-1 deficiency syndrome

034

CREST syndrome diagnosed because of faulty point-of-care glycaemia: a case report

035

Medullary thyroid carcinoma in two patients with neurofibromatosis type 1

036

The phenotypic diversity of the 22q11.2 deletion syndrome and hypoparathyrodism

037

Pheochromocytoma-induced Takotsubo syndrome: when you hear hoofbeats, it may be a zebra!

038

Severe hypocalcemia after a single denosumab injection and tumor-induced persistent hypophosphatemia in a patient with metastatic prostate cancer

039

Prepubertal gynecomastia: what to suspect first?

040